Janus Henderson Group PLC Biogen Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Biogen Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 21,129 shares of BIIB stock, worth $4.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,129

Previous 35,159 39.9%

Holding current value

$4.21 Million

Previous $7.58 Million 35.39%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $2.67 Million - $3.32 Million	-14,030 Reduced 39.9%	21,129 $4.9 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $2.97 Million - $3.74 Million	13,985 Added 66.05%	35,159 $7.58 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $19,142 - $23,042	86 Added 0.41%	21,174 $5.48 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $255,073 - $287,891	1,007 Added 5.01%	21,088 $5.42 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $320,666 - $370,539	-1,165 Reduced 5.48%	20,081 $5.72 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $577,516 - $658,057	2,251 Added 11.85%	21,246 $5.91 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $589,194 - $715,884	2,334 Added 14.01%	18,995 $5.26 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $319,486 - $440,542	-1,641 Reduced 8.97%	16,661 $4.45 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $63.9 Million - $76 Million	-340,693 Reduced 94.9%	18,302 $3.73 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $11.2 Million - $14.1 Million	57,550 Added 19.09%	358,995 $75.6 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $36.9 Million - $47.4 Million	164,593 Added 120.27%	301,445 $72.3 Million
Q3 2021 Nov 16, 2021	BUY	$282.99 - $369.05 $13.6 Million - $17.7 Million	47,905 Added 53.86%	136,852 $38.7 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $3.82 Million - $6.12 Million	14,746 Added 19.87%	88,947 $30.8 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $9.18 Million - $10.8 Million	-37,796 Reduced 33.75%	74,201 $20.8 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.87 Million - $2.82 Million	-7,933 Reduced 6.61%	111,997 $27.4 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $1.88 Million - $2.18 Million	-7,117 Reduced 5.6%	119,930 $34 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $12.3 Million - $16.3 Million	47,633 Added 59.98%	127,047 $34 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $697,128 - $884,316	-2,593 Reduced 3.16%	79,414 $25.1 Million
Q4 2019 Feb 18, 2020	BUY	$220.06 - $304.07 $587,340 - $811,562	2,669 Added 3.36%	82,007 $24.3 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $447,274 - $501,661	-2,057 Reduced 2.53%	79,338 $18.5 Million
Q2 2019 Jul 31, 2019	BUY	$219.29 - $241.72 $719,490 - $793,083	3,281 Added 4.2%	81,395 $19 Million
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $77.8 Million - $122 Million	-359,200 Reduced 82.14%	78,114 $18.5 Million
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $21.9 Million - $27.8 Million	-78,806 Reduced 15.27%	437,314 $132 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $317 Million - $414 Million	-1,079,866 Reduced 67.66%	516,120 $182 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $7.82 Million - $9.32 Million	30,353 Added 1.94%	1,595,986 $463 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $9.69 Million - $13.7 Million	37,247 Added 2.44%	1,565,633 $429 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $27.1 Million - $30.4 Million	88,235 Added 6.13%	1,528,386 $487 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $1.52 Million - $1.78 Million	-5,409 Reduced 0.37%	1,440,151 $0
Q2 2017 Aug 17, 2017	BUY	N/A	1,445,560	1,445,560 $392 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Biogen Inc. Transaction History